• Meeting time:2014.9.18-2014.9.22
  • Abstract Submission Deadline: 2014.7.31
  • Registration Deadline: 2014.8.31

Venue: Guangzhou Baiyun International Convention Center 
Meeting Time: September 18, 2014 - September 22, 2014
The Breast Specialist Branch of Guangdong Medical Doctor Association 

Sun Yat-Sen Memorial Hospital of SYSU 

The Third Affiliated Hospital of SYSU

The First Affliated Hospital of Shenzhen University

Home >> President of the Assembly membersPresident of the Assembly members
Erwei Song, Prof. Dr. med.,
Erwei Song, Prof. Dr. med.,

Erwei Song, Prof. Dr. med., Vice Dean of Sun Yat-sen Memorial Hospital,SunYat-senUniversity


Professor Song graduated fromZhongshanSchoolof medicine,SunYat-senUniversity. He received his MD degree fromSunYat-senUniversityin 2000. In 1999 and 2002, he joint the medical school of the University Duisburg-Essen in German and Harvard's CBR Institute for Biomedical Research in US as a postdoctoral fellow, respectively. He was promoted as an instructor of Harvard medical school in 2004. In the same year, he went back to Sun Yat-sen university and appointed as a researcher inSunYat-senUniversity. In 2007, he was appointed as National Chang-Jiang scholar by the Ministry of education of P.R.China. In 2009, he was rewarded as Chinese medical board (CMB) distinguished professor and promoted as the chief scientist of the National key fundamental research project (973 project). He is the member of Standing Committee of the Chinese Anti-Cancer Association, committee of breast cancer society. He is the chairman-elect of the Guangdong Anti-Cancer association, committee of breast cancer society. Professor Song and his team is dedicated in basic research concerning the biology of breast cancer and its therapeutic strategies. His distinguished researches are sponsored by National Science Foundation for Distinguished Young Scholars of China, the State Key Program of National Natural Science of China, A3 foresight Program by National Natural Science Foundation of China, the Special Program for Key Basic Research of the Ministry of Science and Technology of China, the key Clinical Program of the Ministry of Health of China and the exploratory program of the 863 project. His works were honored as one of the top 10 breakthroughs of the year in 2003 by Science and one of the top 10 breakthroughs inChineseUniversityby Ministry of Education inChina. He was the corresponding author or the first author in 45 articles that published in《Cell》、《Cancer Cell》、《Nature Medicine》、《Nature Biotechnology》、《Science Translational Medicine》、《Journal of Biological Chemistry》、《Oncogene》、《Clinical Cancer Research》、《Journal of Virology》、《Surgery》、《Kidney International》、《British Journal of Cancer》 and 《ACS Nano》, the total Impact factor is more than 327.As a co-author, he published 30 articles in journals such as 《PNAS》 and 《Blood》. In total, his articles have been cited for more than 3000 times before February, 2013. He was the Chief editor of the 《The biological rational and application of RNA interference.》, which was published by the Higher education press. He was also the Chief editor of the 《Small RNA: Basic Research and Clinical Application》, which was published by the Beijing Technology press. He was also one of the authors of 《Gene Silencing by RNA Interference: Technology and Application》 that published by CRC Press.

Key Recent Publications:


1. Su S*, Liu Q*, Chen J, Chen J, Chen F, He C, Huang D, Wu W, Lin L, Huang W, Zhang J, Cui X, Zheng F, Li H, Yao H, Su F, Song E#. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell 2014.

2. Chen J*, Yao Y*, Gong C*, Yu F*, Sun S, Chen J, Liu B, Deng H, Wang F, Lin L, Yao H, Sun F, Karen S. Anderson, Liu Q, Mark E. Ewen, Yao X#, Song E#. CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3. Cancer Cell 2011; 19(4), 541–555.

3. Yao Y*, Sun T*, Huang S, Dou S, Lin L, Chen J, Ruan J, Mao C, Yu F, Zeng M, Zhang J, Liu Q,  Su F, Zhang P, Lieberman J#, Wang J#, Song E#. Targeted Delivery of PLK1-siRNA by ScFv Suppresses Her2+ Breast Cancer Growth and Metastasis. Science Translational Medicine 2012; 4:130ra48.